XML 43 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Note 11 - Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2021
Notes Tables  
Share-based Payment Arrangement, Cost by Plan [Table Text Block]
  

Three Months Ended September 30,

  Nine Months Ended September 30, 
  2021  2020  2021  2020 

Equity Classified Awards

                
Stock options                
Research and development $188  $  $188  $ 
Selling, general and administrative  598      598    
                 

Restricted stock

                

Research and development

  273   142   519   353 
Selling, general and administrative  821   500   1,995   1,122 
                 

Total equity classified awards

  1,880   642   3,300   1,475 
                 

Liability Classified Awards

                
Restricted stock                
Selling, general and administrative  2,368      2,368    
                 
Stock appreciation rights                
Research and development  (40)  16   149   (61)

Selling, general and administrative

  (2)  16   6   (67)
                 

Total liability classified awards

  2,326   32   2,523   (128)
                 

Total stock-based compensation

 $4,206  $674  $5,823  $1,347 
Share-based Payment Arrangement, Option, Activity [Table Text Block]

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

 

Weighted-

 

Remaining

 

 

 

 

 

 

 

 

 

 

Average

 

Contractual

 

Aggregate

 

 

 

 

Number of

 

 

Exercise

 

Term

 

Intrinsic

 

 

 

 

Options

 

 

Price (1)

 

(years)

 

Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options outstanding at December 31, 2020

 

1,552

 

 

$

556.13

 

5.6

 

$

 

 

Granted

 

4,670,324

 

 

$

4.98

 

  

 

  

 

Canceled or forfeited

 

(1,597

)

 

$

130.67  

 

 

  

 

Exercised

 

 

 

$

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

  

 

Options outstanding at September 30, 2021

 

4,670,279 

 

$

5.12

 

9.9

 

$

7,750,148  

 

 

 

 

 

 

 

 

 

 

 

  

 

Options exercisable at September 30, 2021

 

1,515

 

 

$

431.34 4.9

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

  

 

Options vested and expected to vest at September 30, 2021

 

4,435,359 

 

$

5.12 9.9

 

$

7,360,181  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

Period Ended

 

Total Stock Options Granted 

 

Weighted-Average Exercise Price 

 

Weighted-Average Expected Term

 

Weighted Average Volatility

 

Weighted-Average Risk-Free Interest Rate

 

Expected Dividends

 

Weighted-Average Grant Date Fair Value

September 30, 2021

 

4,670,324

 

4.98

 

5.75 years 

 

144%

 

0.87%

 

$

0

 

$

4.57

Schedule of Nonvested Share Activity [Table Text Block]

 

 

 

 

 

Weighted-

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant-Date

 

 

 

Shares

 

 

Fair Value

 

 

 

 

 

 

 

 

 

Non-vested at December 31, 2020

 

4,701,556 

 

$

0.79 

Granted

 

4,807,378 

 

$

5.08

 

Vested

 

(2,585,547)

 

$

0.99 

Canceled or forfeited

 

(129,149)

 

$

0.84

 

 

 

  

 

 

 

 

Non-vested at September 30, 2021

 

6,794,238 

 

$

3.75